Vascular Biogenics Ltd (NASDAQ:VBLT)

0.1495
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
0.10
Today|||52-Week Range
2.20
+24.58%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +3,244.48% increase from the last price of 0.15.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Vascular Biogenics Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$500.0K
Reporting Date
Mar 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.67%
 
 
 
 
 
 
Growthannually -15.56%
 
 
 
 
 
 

Sales

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 43.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.